BIOMAT Database Logo BIOMAT Database Logo

[Therapeutic monitoring from the point of view of the clinical pharmacologist]. 1986

L M Wichliński

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D004358 Drug Therapy The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER. Chemotherapy,Pharmacotherapy,Therapy, Drug,Chemotherapies,Drug Therapies,Pharmacotherapies,Therapies, Drug
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L M Wichliński
[An evaluation of non-clinical animal data from the point of view of a clinical pharmacologist].
January 1999, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
L M Wichliński
[Antibiotics. New aspects from the point of view of a pharmacologist].
May 1974, Fortschritte der Medizin,
L M Wichliński
Drug therapy in the elderly: the problem from the point of view of a clinical pharmacologist.
December 1987, Clinical pharmacology and therapeutics,
L M Wichliński
Trade names or approved names. Point II. Points of view. The clinical pharmacologist.
February 1974, Postgraduate medical journal,
L M Wichliński
Within-patient variability of mycophenolic acid exposure: therapeutic drug monitoring from a clinical point of view.
February 2006, Therapeutic drug monitoring,
L M Wichliński
[Mediastinal tumors studied from the clinical and therapeutic point of view].
December 1958, Strasbourg medical,
L M Wichliński
[CLINICAL CLASSIFICATION OF CHRONIC BRONCHITIS FROM THE THERAPEUTIC STAND POINT OF VIEW].
July 1964, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
L M Wichliński
[Problems in dose finding from the view of the clinical pharmacologist (author's transl)].
February 1977, Arzneimittel-Forschung,
L M Wichliński
[Theoretical and practical problems concerning therapeutic drug monitoring from the viewpoint of the pharmacologist].
May 1996, Orvosi hetilap,
L M Wichliński
Monitoring medicines use: the role of the clinical pharmacologist.
October 2012, British journal of clinical pharmacology,
Copied contents to your clipboard!